0001181431-12-024891.txt : 20120419 0001181431-12-024891.hdr.sgml : 20120419 20120419183656 ACCESSION NUMBER: 0001181431-12-024891 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110514 FILED AS OF DATE: 20120419 DATE AS OF CHANGE: 20120419 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001369786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 BUSINESS PHONE: 847-908-1604 MAIL ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 FORMER COMPANY: FORMER CONFORMED NAME: Sagent Holding Co. DATE OF NAME CHANGE: 20090529 FORMER COMPANY: FORMER CONFORMED NAME: NHS PHARMACEUTICALS DATE OF NAME CHANGE: 20060720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLANAGAN ROBERT J CENTRAL INDEX KEY: 0001251512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35144 FILM NUMBER: 12769265 MAIL ADDRESS: STREET 1: C/O SAGENT PHARMACEUTICALS, INC. STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 4 1 rrd342154.xml X0305 4 2011-05-14 0 0001369786 Sagent Pharmaceuticals, Inc. SGNT 0001251512 FLANAGAN ROBERT J C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 1 0 0 0 Common Stock 2011-05-14 4 M 0 1277 4.23 A 2552 D Common Stock 2011-12-16 4 G 0 1000 0 D 2000 I See Footnote Common Stock 1109769 I See Footnote Stock Option to Buy/Restricted Stock 4.23 2011-05-14 4 M 0 1277 0 D 2019-05-13 Common Stock 1277 2551 D Vesting of restricted stock resulting from early exercise of stock options. The shares reported are held by Flanagan Family Limited Partnership. Mr. Flanagan is a managing member of E.O. Flanagan LLC, the general partner of Flanagan Family Limited Partnership. The shares reported are held of record by CNF Investments II, LLC. Voting and investment decisions with respect to all shares held by CNF Investments II, LLC are exercised by its managing member, Mr. Flanagan. Accordingly, Mr. Flanagan may be deemed the beneficial owner of such shares. Stock option granted on May 13, 2009 and vests 25% per year over four years. The 1,277 stock options reported had been early-exercised and were considered restricted stock. /s/ Robert J. Flanagan 2012-04-19